Table 1.
Variable | Patients enrolled n = 52 (%) |
Patients with one-year follow-up n = 37(%) |
|
---|---|---|---|
Age years | ≤ 60 ≥ 60 |
20 (38.4) 32 (61.6) |
13 (35.1) 24 (64.9) |
Sex | Female Male |
24 (45.3) 28 (53.8) |
16 (43.2) 21 (56.8) |
aECOG | 0–1 > 2 |
46 (88.5) 6 (11.5) |
34 (91.9) 3 (8.1) |
Smoking history | Yes No |
22 (42.3) 30 (57.7) |
20 (54.1) 17 (45.9) |
Current smoking | Yes No |
7 (13.5) 45 (86.5) |
5 (13.5) 32 (86.5) |
Tobacco index | Package/Year | 38 (0.3–111) | 34(0.3–111) |
Histology | Adenocarcinoma Others |
35 (67.3) 17 (32.7) |
25 (67.6) 12 (32.4) |
bClinical stage | III IV |
26 (50) 26 (50) |
17 (45.9) 20 (54.1) |
cLocalization | Superior Medium Inferior |
11 (21.1) 12 (23.1) 29 (55.8) |
15 (40.5) 9 (24.3) 13 (35.2) |
aECOG (Eastern Cooperative Oncology Group), performance status 0-fully active, 1-Restricted in physically strenuous activity, 2-Ambulatory and capable of all selfcare, 3-Capable of only limited selfcare, 4-Completely disabled and 5-Dead. b7th lung cancer TNM classification and staging system. cCT scan tumor localization